/PRNewswire/ Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board").
SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 /PRNewswire/ Titan Pharmaceuticals, Inc. today announced that it has expanded its Board of Directors from five to eleven and appointed six new.
Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Titan Pharmaceuticals, Inc. announced that data from continuing studies of its ProNeura®-based TP-2021 implant in an established animal model.
/PRNewswire/ Titan Pharmaceuticals, Inc. announced that data from continuing studies of its ProNeura®-based TP-2021 implant in an established animal model.